Peer Review History
| Original SubmissionApril 7, 2023 |
|---|
|
Dear Dr Salton, Thank you for submitting your manuscript from Review Commons entitled "Hematopoiesis and cell growth are differentially regulated by TAL1 isoforms" for consideration as a Research Article by PLOS Biology. Please accept my sincere apologies for the great delay in getting back to you as we consulted with an academic editor with the relevant expertise about your submission. I'm writing to let you know that we would like to send a minor revision based on your responses to the previous reviews at Review Commons. However, before we can invite a revision, we need you to complete your submission by providing the metadata that is required for full assessment. To this end, please login to Editorial Manager where you will find the paper in the 'Submissions Needing Revisions' folder on your homepage. Please click 'Revise Submission' from the Action Links and complete all additional questions in the submission questionnaire. Once your full submission is complete, your paper will undergo a series of checks in preparation to issue the decision. After your manuscript has passed the checks we will be able to issue the revision. To provide the metadata for your submission, please Login to Editorial Manager (https://www.editorialmanager.com/pbiology) within two working days, i.e. by Apr 27 2023 11:59PM. During the process of completing your manuscript submission, you will be invited to opt-in to posting your pre-review manuscript as a bioRxiv preprint. Visit http://journals.plos.org/plosbiology/s/preprints for full details. If you consent to posting your current manuscript as a preprint, please upload a single Preprint PDF. Feel free to email us at plosbiology@plos.org if you have any queries relating to your submission. Kind regards, Richard Richard Hodge, PhD Associate Editor, PLOS Biology PLOS Empowering researchers to transform science Carlyle House, Carlyle Road, Cambridge, CB4 3DN, United Kingdom ORCiD I plosbio.org I @PLOSBiology I Blog California (U.S.) corporation #C2354500, based in San Francisco |
| Revision 1 |
|
Dear Dr Salton, Thank you for your patience while we considered your revised manuscript from Review Commons entitled "Hematopoiesis and cell growth are differentially regulated by TAL1 isoforms" for publication as a Research Article at PLOS Biology. Based on our Academic Editor's assessment of your responses to the previous reviews at Review Commons and the revision, I am pleased to say that we are likely to accept this manuscript for publication, provided you satisfactorily address the following data and other policy-related requests that I have provided below (A-I): (A) We would like to suggest the following modification to the title: “"Isoforms of the TAL1 transcription factor have different roles in hematopoiesis and cell growth" (B) In the Methods section of the manuscript, please include the full name of the IACUC/ethics committee that reviewed and approved the animal care and use protocol/permit/project license. Please also include the specific approval number issued by your IACUC to conduct the study, as well as the method of euthanasia used to sacrifice the mice. (C) You may be aware of the PLOS Data Policy, which requires that all data be made available without restriction: http://journals.plos.org/plosbiology/s/data-availability. For more information, please also see this editorial: http://dx.doi.org/10.1371/journal.pbio.1001797 Note that we do not require all raw data. Rather, we ask that all individual quantitative observations that underlie the data summarized in the figures and results of your paper be made available in one of the following forms: -Supplementary files (e.g., excel). Please ensure that all data files are uploaded as 'Supporting Information' and are invariably referred to (in the manuscript, figure legends, and the Description field when uploading your files) using the following format verbatim: S1 Data, S2 Data, etc. Multiple panels of a single or even several figures can be included as multiple sheets in one excel file that is saved using exactly the following convention: S1_Data.xlsx (using an underscore). -Deposition in a publicly available repository. Please also provide the accession code or a reviewer link so that we may view your data before publication. Regardless of the method selected, please ensure that you provide the individual numerical values that underlie the summary data displayed in the following figure panels as they are essential for readers to assess your analysis and to reproduce it: Figure 2A-H, 3A-B, 4C-H, 4J-L, 5C, 5E, 5G, 6A-D, S1A-B, S2D, S2G, S2I, S2J-M, S3A, S3C, S4D-E, S4K, S4N, S5B, S5D-E, S5G, S5I, S5K, S6A, S6D-I NOTE: the numerical data provided should include all replicates AND the way in which the plotted mean and errors were derived (it should not present only the mean/average values). (D) Thank you for depositing the RNA-seq (GSE214833) and ChIP-seq (GSE216684) data in the GEO database. However, I note that the data is currently private and is scheduled to be released on October 1st 2023. At this time, we ask that you please make both datasets publicly available before publication and amend the Data Availability Statement to remove any references to access tokens. (E) Please also ensure that each of the relevant figure legends in your manuscript include information on *WHERE THE UNDERLYING DATA CAN BE FOUND*, and ensure your supplemental data file/s has a legend. (F) We require the original, uncropped and minimally adjusted images supporting all blot and gel results reported in the following figures: Figure 1C, 4A, S2C, S2F, S2H, S3B, S4A-B, S6B-C We will require these files before a manuscript can be accepted so please prepare and upload them now. Please carefully read our guidelines for how to prepare and upload this data: https://journals.plos.org/plosbiology/s/figures#loc-blot-and-gel-reporting-requirements (G) For figures containing FACS data (Figure 5B, 5D, 5F, S5A, S5C, S5F, S5H, S5J), please provide the FCS files and a picture showing the successive plots and gates that were applied to the FCS files to generate the figure. We ask that you please deposit this data in the FlowRepository (https://flowrepository.org/) and provide the accession number/URL of the deposition in the Data Availability Statement in the online submission form. (H) Please note that per journal policy, the model system/species studied should be clearly stated in the abstract of your manuscript. (I) Please ensure that your Data Statement in the submission system accurately describes where your data can be found and is in final format, as it will be published as written there. ------------------------------------------ As you address these items, please take this last chance to review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the cover letter that accompanies your revised manuscript. We expect to receive your revised manuscript within two weeks. To submit your revision, please go to https://www.editorialmanager.com/pbiology/ and log in as an Author. Click the link labelled 'Submissions Needing Revision' to find your submission record. Your revised submission must include the following: - a cover letter that should detail your responses to any editorial requests, if applicable, and whether changes have been made to the reference list - a Response to Reviewers file that provides a detailed response to the reviewers' comments (if applicable) - a track-changes file indicating any changes that you have made to the manuscript. NOTE: If Supporting Information files are included with your article, note that these are not copyedited and will be published as they are submitted. Please ensure that these files are legible and of high quality (at least 300 dpi) in an easily accessible file format. For this reason, please be aware that any references listed in an SI file will not be indexed. For more information, see our Supporting Information guidelines: https://journals.plos.org/plosbiology/s/supporting-information *Published Peer Review History* Please note that you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. Please see here for more details: https://blogs.plos.org/plos/2019/05/plos-journals-now-open-for-published-peer-review/ *Press* Should you, your institution's press office or the journal office choose to press release your paper, please ensure you have opted out of Early Article Posting on the submission form. We ask that you notify us as soon as possible if you or your institution is planning to press release the article. *Protocols deposition* To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols Please do not hesitate to contact me should you have any questions. Kind regards, Richard Richard Hodge, PhD Associate Editor, PLOS Biology PLOS Empowering researchers to transform science Carlyle House, Carlyle Road, Cambridge, CB4 3DN, United Kingdom ORCiD I plosbio.org I @PLOSBiology I Blog California (U.S.) corporation #C2354500, based in San Francisco |
| Revision 2 |
|
Dear Dr Salton, Thank you for the submission of your revised Research Article "Isoforms of the TAL1 transcription factor have different roles in hematopoiesis and cell growth" for publication in PLOS Biology. On behalf of my colleagues and the Academic Editor, Connie Eaves, I am pleased to say that we can accept your manuscript for publication, provided you address any remaining formatting and reporting issues. These will be detailed in an email you should receive within 2-3 business days from our colleagues in the journal operations team; no action is required from you until then. Please note that we will not be able to formally accept your manuscript and schedule it for publication until you have completed any requested changes. Please take a minute to log into Editorial Manager at http://www.editorialmanager.com/pbiology/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production process. PRESS We frequently collaborate with press offices. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximise its impact. If the press office is planning to promote your findings, we would be grateful if they could coordinate with biologypress@plos.org. If you have previously opted in to the early version process, we ask that you notify us immediately of any press plans so that we may opt out on your behalf. We also ask that you take this opportunity to read our Embargo Policy regarding the discussion, promotion and media coverage of work that is yet to be published by PLOS. As your manuscript is not yet published, it is bound by the conditions of our Embargo Policy. Please be aware that this policy is in place both to ensure that any press coverage of your article is fully substantiated and to provide a direct link between such coverage and the published work. For full details of our Embargo Policy, please visit http://www.plos.org/about/media-inquiries/embargo-policy/. Thank you again for choosing PLOS Biology for publication and supporting Open Access publishing. We look forward to publishing your study. Best wishes, Richard Richard Hodge, PhD Associate Editor, PLOS Biology PLOS Empowering researchers to transform science Carlyle House, Carlyle Road, Cambridge, CB4 3DN, United Kingdom ORCiD I plosbio.org I @PLOSBiology I Blog California (U.S.) corporation #C2354500, based in San Francisco |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .